AnalystsEva Fortea Verdejo
Eva Fortea Verdejo's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 5%
#252 out of 5344 analysts
Average Return
+53.99%
Win Rate
78%31 out of 40
Risk vs Reward
Poor
Good

Eva Fortea Verdejo's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Revolution Medicines IncRVMD
+326.69%$46.24$197.30
2025-09-11 -
2026-08-05
Strong Buy
Xencor IncXNCR
+171.04%$7.32$19.84
2025-08-07 -
2026-08-05
Strong Buy
Arcus Biosciences IncRCUS
+149.19%$8.01$19.96
2025-05-07 -
2026-02-12
Strong Buy
Relay Therapeutics IncRLAY
+145.21%$8.03$19.69
2025-12-12 -
2026-08-05
Strong Buy
Merus NvMRUS
+127.08%$41.25$93.67
2025-02-07 -
2025-09-29
Strong Buy

Eva Fortea Verdejo's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Exelixis IncEXEL
3Hold$49.00-13.58%Maintains
24 days ago
Kiniksa Pharmaceuticals International PLCKNSA
6Strong Buy$74.00-5.23%Maintains
24 days ago
Zymeworks IncZYME
6Strong Buy$37.00+57.45%Maintains
a month ago
Nuvalent IncNUVL
2Hold$124.00+0.03%Downgrades
2 months ago
Celcuity IncCELC
2Strong Buy$166.00+78.65%Maintains
2 months ago
Relay Therapeutics IncRLAY
5Strong Buy$21.00+6.65%Maintains
3 months ago
Revolution Medicines IncRVMD
3Strong Buy$167.00-15.36%Maintains
4 months ago
Ideaya Biosciences IncIDYA
2Strong Buy$48.00+33.19%Maintains
4 months ago
Bicara Therapeutics IncBCAX
4Hold$16.00-38.20%Maintains
4 months ago
Sutro Biopharma IncSTRO
1Strong Buy$27.00+7.57%Upgrades
4 months ago
Genmab AGMAB
1Strong Buy$40.00+36.71%Initiates Coverage On
5 months ago
Arcus Biosciences IncRCUS
5Hold$23.00-16.97%Downgrades
6 months ago
Immunocore Holdings PLCIMCR
1Strong Buy$60.00+80.23%Initiates Coverage On
9 months ago
Merus NvMRUS
5Hold$97.00+7.78%Downgrades
10 months ago
Iteos Therapeutics IncITOS
7Hold$11.00+8.37%Maintains
a year ago
Xencor IncXNCR
3Strong Buy$27.00+36.09%Maintains
a year ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.